FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to methods for producing protease inhibitors, particularly serine protease inhibitors.
EFFECT: producing protease inhibitors applicable for treating HCV infections.
43 cl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
DEUTERATED HEPATITIS C PROTEASE INHIBITORS | 2007 |
|
RU2465264C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
SERINE PROTEASE INHIBITORS | 2006 |
|
RU2441020C2 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
NEW METHOD FOR SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2593370C2 |
MODULATORS OF ATP-BINDING CARTRIDGE TRANSPORTERS | 2012 |
|
RU2640420C2 |
PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
Authors
Dates
2012-03-27—Published
2006-08-18—Filed